期刊文献+
共找到8篇文章
< 1 >
每页显示 20 50 100
Influence of the Pre-shock State on the Prognosis of Medical Patients with Sepsis: A Retrospective Cohort Study
1
作者 ZHANG Lei GAI Xiao Yan +5 位作者 LI Xin LIANG Ying WANG Meng ZHAO Fei Fan ZHOU Qing Tao SUN Yong Chang 《Biomedical and Environmental Sciences》 SCIE CAS CSCD 2023年第12期1152-1161,共10页
Objective To investigate the effects of the pre-shock state on the mortality of patients with sepsis.Methods We enrolled patients with sepsis admitted to the medical intensive care unit of a tertiary care university h... Objective To investigate the effects of the pre-shock state on the mortality of patients with sepsis.Methods We enrolled patients with sepsis admitted to the medical intensive care unit of a tertiary care university hospital. These patients were then classified into three groups: sepsis, pre-shock state,and septic shock. The primary outcome was the 28-day mortality rate. The secondary outcomes were the 90-day, 180-day, and 1-year mortality rates.Results A total of 303 patients(groups: sepsis 135 [44.6%]), pre-shock state(93 [30.7%]), and septic shock(75 [24.8%]) completed the 1-year follow-up. The mortality rates at 28 days, 90 days, and 180days and 1 year were significantly higher in the pre-shock state group than those of the sepsis group,but significantly lower than those in the septic shock group, especially among older patients. When compared with the pre-shock state group, the sepsis group had significantly lower mortality risks at 28days, 90 days, and 180 days and 1 year, whereas the sepsis shock group had higher mortality risks at these time points.Conclusion The mortality rates of patients in the pre-shock state were notably different from those of patients with sepsis or septic shock. The introduction of a modified sepsis severity classification, which includes sepsis, pre-shock state, and septic shock, could offer valuable additional prognostic information. 展开更多
关键词 Critical care MORTALITY Pre-shock state SEPSIS Septic shock
下载PDF
Ventilator associated pneumonia following liver transplantation:Etiology,risk factors and outcome 被引量:9
2
作者 Antonio Siniscalchi Lucia Aurini +4 位作者 Beatrice Benini Lorenzo Gamberini Stefano Nava Pierluigi Viale Stefano Faenza 《World Journal of Transplantation》 2016年第2期389-395,共7页
AIM: To determine the incidence, etiology, risk factors and outcome of ventilator-associated pneumonia(VAP) in patients undergoing orthotopic liver transplantation(OLT).METHODS: This retrospective study considered 242... AIM: To determine the incidence, etiology, risk factors and outcome of ventilator-associated pneumonia(VAP) in patients undergoing orthotopic liver transplantation(OLT).METHODS: This retrospective study considered 242 patients undergoing deceased donor OLT. VAP was diagnosed according to clinical and microbiological criteria. RESULTS: VAP occurred in 18(7.4%) patients, with an incidence of 10 per 1000 d of mechanical ventilation(MV). Isolated bacterial etiologic agents were mainly Enterobacteriaceae(79%). Univariate logistic analysis showed that model for end-stage liver disease(MELD) score, pre-operative hospitalization, treatment with terlipressin, Child-Turcotte-Pugh score, days of MV and red cell transfusion were risk factors for VAP. Multivariateanalysis, considering significant risk factors in univariate analysis, demonstrated that pneumonia was strongly associated with terlipressin usage, pre-operative hospitalization, days of MV and red cell transfusion. Mortality rate was 22% in the VAP group vs 4% in the group without VAP. CONCLUSION: Our data suggest that VAP is an important cause of nosocomial infection during postoperative period in OLT patients. MELD score was a significant risk factor in univariate analysis. Multiple transfusions, treatment with terlipressin, preoperative hospitalization rather than called to the hospital while at home and days of MV constitute important risk factors for VAP development. 展开更多
关键词 Liver TRANSPLANTATION VENTILATOR associated PNEUMONIA PERIOPERATIVE period Infection
下载PDF
The efficacy of TKIs in treatment of human primary small cell lung cancer xenograft model in vivo
3
作者 Yu-hua ZHANG Liang SUN +1 位作者 Bin LIU Guo-qiang LI 《中国应用生理学杂志》 CAS CSCD 2016年第6期525-528,共4页
Objective: To study the treatmaient of non-small cell lung cancer, we established the HU-Prim allograft transplantation tumor model. Methods: The fresh tumor samples were transplanted in the right scapular subcutaneou... Objective: To study the treatmaient of non-small cell lung cancer, we established the HU-Prim allograft transplantation tumor model. Methods: The fresh tumor samples were transplanted in the right scapular subcutaneous layer of the severe combined immunodeficient Non-obese diabetic/severe combined immunodeficient(NOD/SCID) mice. The pathological features of the tumors were observed. Nonnecrotic tissue was inoculated subcutaneously into the right axillary. When the tumor in burdened rat grew approximately 100 mm3, according to the tumor size all the animals were divided into the following four groups, eight rats in each group: solvent control group, gefitinib group(100 mg/kg), erlotinib group(50 mg/kg), afatinib group(20 mg/kg). Aniamals were treated with drugs by intragastric(i.g.) administrated, once daily, for consecutively 14 days. Measure the tumor size 2-3 times every week. Results: Hu Prime1-NSCLC mutant sensitive xenograft model research data showed that reversible tyrosine kinase inhibitors gefitinib, erlotinib and irreversible tyrosine kinase inhibitor afatinib could effectively inhibit tumor growth in EGFR positive NSCLC allografts model. The pharmacodynamic activity of irreversible inhibitor was better than that of the reversible inhibitor. Specimens from clinical anthropogenic tumor retain characteristics of the human primary malignancy, histopathology, biological characteristics, and tumor markers, etc., which can more accurately reflect the characteristics of the tumor and the impact of interventions. Conclusion: The model is not only a good antitumor drug experimental platform, but also a new evaluation tool of individualized medication. 展开更多
关键词 非小细胞肺癌 肿瘤模型 异种移植 药物治疗 酪氨酸激酶抑制剂 人类 原发性 组织病理学
下载PDF
Cardiac mapping of electrical impedance tomography by means of a wavelet model
4
作者 Harki Tanaka Neli Regina Siqueira Ortega +2 位作者 Andre Hovnanian Carlos Roberto Ribeiro de Carvalho Marcelo Britto Passos Amato 《World Journal of Cardiovascular Diseases》 2013年第7期464-470,共7页
To improve the identification of cardiac regions in Electrical impedance tomography (EIT) pulmonary perfusion images, a model of wavelet transform was developed. The main goal was to generate maps of the heart using E... To improve the identification of cardiac regions in Electrical impedance tomography (EIT) pulmonary perfusion images, a model of wavelet transform was developed. The main goal was to generate maps of the heart using EIT images in a controlled animal experiment using a healthy pig and in two human volunteers. The model was capable of identifying the heart regions, demonstrated robustness and generated satisfactory results. The pig images were compared to perfusion images obtained using injection of a hypertonic solution and achieved an average area of the ROC curve of 0.88. The human images were qualitatively compared with Computerized Tomography scan (CT-scan) images. 展开更多
关键词 Electrical IMPEDANCE TOMOGRAPHY HEART IMAGE Analysis IMAGE Segmentation WAVELET
下载PDF
Promotional effects of exogenous stimulation with pulsed electromagnetic fields on skin wound healing in diabetic rats
5
作者 Yan Han Ze-Dong Yan Shu-Hua Ge 《Journal of Hainan Medical University》 2019年第5期1-5,共5页
Objective:The current study aims to identify the effects of exogenous application of pulsed electromagnetic fields on skin wound healing in diabetic rats, and thus provides experimental evidence for its more scientifi... Objective:The current study aims to identify the effects of exogenous application of pulsed electromagnetic fields on skin wound healing in diabetic rats, and thus provides experimental evidence for its more scientific clinical application in the future.Methods: The diabetic animal models were established via intraperitoneal injection of streptozotocin in 4-month-old male rats. Fourth eight rats were randomly assigned into the diabetes group (DM) and diabetes coupled with pulsed electromagnetic fields (DM+PEMF) group. Another 24 normal rats were used as the blank control group (Control). Then, all the rats in the three groups were subjected to dorsal surgery for the establishment of soft tissue wound model (circular wound with the diameter of 2 cm). Then, the rats in the DM+PEMF group were subjected to pulsed electromagnetic fields stimulation. Then, 6 rats in each group were sacrificed at Day 5, 12 and 19 post surgery. The glucose levels, wound closure, wound healing time and tissue tensile strength were examined and analyzed.Results: Pulsed electromagnetic fields significantly increased the wound closure rate in diabetic rats at Day 5, 12 and 19 post surgery, decreased overall wound healing period in diabetic rats, and also enhanced tissue tensile strength in diabetic rats at Day 5, 12 and 19 post surgery.Conclusion: Low-intensity pulsed electromagnetic fields can significantly accelerate diabetic wound healing process, and also improve diabetic tissue repair capacity. This study may be helpful for providing more scientific and reasonable experimental evidence for the treatment of pulsed electromagnetic fields on diabetic wound healing in clinics. 展开更多
关键词 PULSED electromagnetic fields Diabetes Sskin WOUND Tissue TENSILE strength GLUCOSE
下载PDF
Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease 被引量:31
6
作者 Wei Liu Zhao-Wu Tao +9 位作者 Lei Wang Ming-Li Yuan Kui Liu Ling Zhou Shuang Wei Yan Deng Jing Liu Hui-Guo Liu Ming Yang Yi Hu 《Chinese Medical Journal》 SCIE CAS CSCD 2020年第9期1032-1038,共7页
Background Since early December 2019,the 2019 novel coronavirus disease(COVID-19)has caused pneumonia epidemic in Wuhan,Hubei province of China.This study aimed to investigate the factors affecting the progression of ... Background Since early December 2019,the 2019 novel coronavirus disease(COVID-19)has caused pneumonia epidemic in Wuhan,Hubei province of China.This study aimed to investigate the factors affecting the progression of pneumonia in COVID-19 patients.Associated results will be used to evaluate the prognosis and to find the optimal treatment regimens for COVID-19 pneumonia.Methods Patients tested positive for the COVID-19 based on nucleic acid detection were included in this study.Patients were admitted to 3 tertiary hospitals in Wuhan between December 30,2019,and January 15,2020.Individual data,laboratory indices,imaging characteristics,and clinical data were collected,and statistical analysis was performed.Based on clinical typing results,the patients were divided into a progression group or an improvement/stabilization group.Continuous variables were analyzed using independent samples t-test or Mann-Whitney U test.Categorical variables were analyzed using Chi-squared test or Fisher’s exact test.Logistic regression analysis was performed to explore the risk factors for disease progression.Results Seventy-eight patients with COVID-19-induced pneumonia met the inclusion criteria and were included in this study.Efficacy evaluation at 2 weeks after hospitalization indicated that 11 patients(14.1%)had deteriorated,and 67 patients(85.9%)had improved/stabilized.The patients in the progression group were significantly older than those in the disease improvement/stabilization group(66[51,70]vs.37[32,41]years,U=4.932,P=0.001).The progression group had a significantly higher proportion of patients with a history of smoking than the improvement/stabilization group(27.3%vs.3.0%,χ^2=9.291,P=0.018).For all the 78 patients,fever was the most common initial symptom,and the maximum body temperature at admission was significantly higher in the progression group than in the improvement/stabilization group(38.2[37.8,38.6]vs.37.5[37.0,38.4]°C,U=2.057,P=0.027).Moreover,the proportion of patients with respiratory failure(54.5%vs.20.9%,χ^2=5.611,P=0.028)and respiratory rate(34[18,48]vs.24[16,60]breaths/min,U=4.030,P=0.004)were significantly higher in the progression group than in the improvement/stabilization group.C-reactive protein was significantly elevated in the progression group compared to the improvement/stabilization group(38.9[14.3,64.8]vs.10.6[1.9,33.1]mg/L,U=1.315,P=0.024).Albumin was significantly lower in the progression group than in the improvement/stabilization group(36.62±6.60 vs.41.27±4.55 g/L,U=2.843,P=0.006).Patients in the progression group were more likely to receive high-level respiratory support than in the improvement/stabilization group(χ^2=16.01,P=0.001).Multivariate logistic analysis indicated that age(odds ratio[OR],8.546;95%confidence interval[CI]:1.628-44.864;P=0.011),history of smoking(OR,14.285;95%CI:1.577-25.000;P=0.018),maximum body temperature at admission(OR,8.999;95%CI:1.036-78.147,P=0.046),respiratory failure(OR,8.772,95%CI:1.942-40.000;P=0.016),albumin(OR,7.353,95%CI:1.098-50.000;P=0.003),and C-reactive protein(OR,10.530;95%CI:1.224-34.701,P=0.028)were risk factors for disease progression.Conclusions Several factors that led to the progression of COVID-19 pneumonia were identified,including age,history of smoking,maximum body temperature at admission,respiratory failure,albumin,and C-reactive protein.These results can be used to further enhance the ability of management of COVID-19 pneumonia. 展开更多
关键词 2019 Novel coronavirus disease Disease outcome PREDICTORS
原文传递
Altered diaphragmatic contractile properties after high airway pressure controlled mechanical ventilation 被引量:5
7
作者 JIAO Guang-yu LIU Chun-li +5 位作者 NIE Zhi-wei LIU Dong-juan HE Ping LIU Jing XIA Ning LI Gen-song 《Chinese Medical Journal》 SCIE CAS CSCD 2006年第2期151-155,共5页
关键词 隔膜疾病 压力控制 呼吸管理 治疗
原文传递
Correlation of ARNTL2 with Immune Infiltration and Its Role as a Potential Prognostic Biomarker in Lung Adenocarcinoma
8
作者 Junjie Pan Hongkuan Yang +1 位作者 Lihong Zhu Yafang Lou 《Clinical Complementary Medicine and Pharmacology》 2021年第1期32-40,共9页
Background:ARNTL2 is a core component of the circadian clock genes and plays regulatory roles in the cell cycle and immune infiltration,but its mechanism in lung cancer(LC)remains unclear.Objective:To investigate the ... Background:ARNTL2 is a core component of the circadian clock genes and plays regulatory roles in the cell cycle and immune infiltration,but its mechanism in lung cancer(LC)remains unclear.Objective:To investigate the clinical and therapeutic value of ARNTL2 in LC.Methods:The Oncomine and Cancer Cell Line Encyclopedia(CCLE)databases were adopted for assessing the ARNTL2 expression,after which the Kaplan-Meier plotter and Gene Expression Profiling Interactive Analysis 2(GEPIA2)databases were used to assess the correlation of ARNTL2 with prognosis.The univariate and multi-variate Cox regression analyses were utilized to identify independent prognostic factors.Also,we explored how ARNTL2 expression is related to immune infiltration,and immunomodulators in non-small lung cancer(NSCLC)using the Tumor Immune Estimation Resource(TIMER)database,TISIDB database and Gene Set Enrichment Analysis(GSEA).Finally,coexpression of ARNTL2 and PD-L1 in lung adenocarcinoma(LUAD)was verified via immunofluorescence staining and COXPRESdb v7 database.Results:Our study demonstrated a remarkable upregulated expression of ARNTL2 in multiple cell lines and can-cers,including NSCLC.Prognostic analysis displayed a remarkable correlation between high ARNTL2 expression and unfavorable overall survival(OS)and first progressive(FP)survival among patients ailing from LUAD,and ARNTL2 was an independent predictor of prognosis for LUAD patients.GSEA analysis showed that overexpres-sion of ARNTL2 was significantly linked with cell cycle and immunity.Furthermore,we reported a correlation of ARNTL2 expression with immunomodulators and lymphocytes.Immunofluorescence staining revealed that ARNTL2 and PD-L1 were elevated relative to normal tissue for LUAD,and colocalization of them was observed.Conclusion:Elevated ARNTL2 expression in LUAD revealed the prognostic values and its prospective role as a target for cell cycle and immune therapy. 展开更多
关键词 ARNTL2 Lung adenocarcinoma PROGNOSIS Cell cycle Immune infiltration
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部